| Aurum Resource Limited (AUE) ORDINARY FULLY PAID |
Materials |
$216 |
Aurum hits 277 g/t gold at Boundiali BM Target 3
|
18 Dec 2024 9:32AM |
$0.330 |
$0.628 |
risen by
90.15%
|
|
AUE - Price-sensitive ASX Announcement
Full Release
Key Points
- Aurum reports high-grade gold intercepts from Boundiali Gold Project.
- Best intercept of 1.19m at 277.54 g/t Au from 31m depth.
- Exploration includes 38 diamond holes totaling 10,089.90m.
- Drilling continues with a target of 50,000m in CY2024.
- Takeover of Mako Gold progressing with over 70% ownership.
- Excellent metallurgical results with over 95% gold recovery.
- Inaugural Mineral Resource Estimate expected by end of CY2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Helia Group Limited (HLI) ORDINARY FULLY PAID |
Financials |
$1,526 |
Becoming a substantial holder
|
18 Dec 2024 9:31AM |
$4.450 |
$5.600 |
risen by
25.84%
|
|
| Bellavista Resources Limited (BVR) ORDINARY FULLY PAID |
Materials |
$52 |
Change in substantial holding
|
18 Dec 2024 9:31AM |
$0.430 |
$0.510 |
risen by
18.60%
|
|
| National Australia Bank Limited (NAB) ORDINARY FULLY PAID |
Financials |
$123,089 |
2024 AGM Chair and CEO Address and Proxy Summary
|
18 Dec 2024 9:30AM |
$38.190 |
$40.180 |
risen by
5.21%
|
|
| Triangle Energy (Global) Limited (TEG) ORDINARY FULLY PAID |
Energy |
$7 |
Cliff Head Sale Update
|
18 Dec 2024 9:29AM |
$0.006 |
$0.003 |
fallen by
50%
|
|
TEG - Price-sensitive ASX Announcement
Full Release
Key Points
- First payment of $900,000 for Cliff Head project not received.
- Triangle Energy reserves rights regarding the agreement with Pilot Energy.
- Remaining payment of $4.85 million due in five installments from February to June 2025.
- Further payments include $4 million on license award and up to $7.5 million in royalties.
- Managing Director expressed disappointment over Pilot's failure to meet payment deadline.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Anax Metals Limited (ANX) ORDINARY FULLY PAID |
Materials |
$7 |
High copper grades and new soil anomalies at Evelyn
|
18 Dec 2024 9:29AM |
$0.010 |
$0.008 |
fallen by
20%
|
|
ANX - Price-sensitive ASX Announcement
Full Release
Key Points
- Rock chip samples reveal high grades of up to 14.6% Cu at Evelyn South.
- Soil geochemical studies indicate a significant copper anomaly extending 400 meters.
- Three new coincident Cu-Zn-Co anomalies identified via UltraFineTM soil analysis.
- Evidence of base-metal mineralisation along a >2km corridor at Evelyn West.
- Plans for RC drilling to commence in early 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tambourah Metals Ltd (TMB) ORDINARY FULLY PAID |
Materials |
$22 |
Proposed Acquisition of Critical Minerals at Speewah
|
18 Dec 2024 9:28AM |
$0.025 |
$0.087 |
risen by
248%
|
|
TMB - Price-sensitive ASX Announcement
Full Release
Key Points
- Opportunity to acquire 80% of Speewah exploration licence E80/5889, 110km southwest of Kununurra in WA, subject to shareholder approval.
- Represents an extension of the Company’s critical minerals portfolio into an area of significant endowment.
- Speewah Dome is associated with a range of in-demand commodities, including critical minerals fluorine and antimony.
- Major deposits of fluorine and vanadium-titanium include Tivan Limited’s Speewah Fluorite deposit.
- Multiple exploration targets within E80/5889 include historic vein-hosted copper, gold, silver, lead, and antimony prospects.
- Tambourah believes the project has potential to host critical minerals essential for AI and energy transition.
- Exploration licence E80/5889 covers an area of 181 sq.km and is located over the northern half of the Speewah Dome.
- Large scale structures traverse the Speewah Dome into E80/5889, hosting significant mineralisation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Blue Star Helium Limited (BNL) ORDINARY FULLY PAID |
Energy |
$25 |
Suspension from Quotation
|
18 Dec 2024 9:27AM |
$0.005 |
$0.007 |
risen by
55.56%
|
|
BNL - Price-sensitive ASX Announcement
Full Release
Key Points
- BNL requested suspension of securities from quotation.
- Suspension is under ASX Listing Rule 17.2.
- Request made pending an announcement on acquisition update.
- Voluntary suspension to last until at least 27 December 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Xero Limited (XRO) ORDINARY FULLY PAID |
Information Technology |
$20,407 |
Notification regarding unquoted securities - XRO
|
18 Dec 2024 9:27AM |
$171.110 |
$120.210 |
fallen by
29.75%
|
|
| Ecofibre Limited (EOF) ORDINARY FULLY PAID |
Health Care |
- |
Ecofibre completes sale and leaseback of US properties
|
18 Dec 2024 9:27AM |
$0.026 |
$0.020 |
fallen by
23.08%
|
|
EOF - Price-sensitive ASX Announcement
Full Release
Key Points
- Ecofibre Limited completes sale and leaseback of US properties.
- The properties are located in Greensboro, North Carolina, and Georgetown, Kentucky.
- The total sale price for the properties is USD 9.7 million.
- USD 9 million of the sale proceeds will repay a secured lender.
- The leaseback includes a 10-year term with rent escalations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tryptamine Therapeutics Limited (TYP) ORDINARY FULLY PAID |
Health Care |
$53 |
Positive interim results in Phase 2a TRP-8802 IBS trial
|
18 Dec 2024 9:27AM |
$0.038 |
$0.034 |
fallen by
10.53%
|
|
TYP - Price-sensitive ASX Announcement
Full Release
Key Points
- Positive interim results in Phase 2a TRP-8802 IBS trial.
- 75% of patients reported reduction in abdominal pain and GI-associated anxiety.
- Study conducted at Massachusetts General Hospital.
- TRP-8802 is an oral psilocybin treatment.
- TRP-8803 is an innovative IV-infused psilocin formulation.
- Results indicate IBS could be a viable treatment target.
- Study expected to complete on time during H1 CY25.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| DigitalX Limited (DCC) ORDINARY FULLY PAID |
Information Technology |
$70 |
Proposed issue of securities - DCC
|
18 Dec 2024 9:27AM |
$0.054 |
$0.047 |
fallen by
12.96%
|
|
| DigitalX Limited (DCC) ORDINARY FULLY PAID |
Information Technology |
$70 |
Capital Raising and Appointment of Strategic Advisor
|
18 Dec 2024 9:27AM |
$0.054 |
$0.047 |
fallen by
12.96%
|
|
DCC - Price-sensitive ASX Announcement
Full Release
Key Points
- Applications received for a private placement to raise $10.3 million.
- Company to undertake rights issue to raise up to an additional $5.09 million.
- Appointment of Mr Antanas Guoga as a strategic advisor.
- Capital raising will be enhanced by around 41 Bitcoin from Mt Gox administrators.
- Directors of the Company committed $611,000 under the Placement.
- Mr Guoga invested $4.7 million under the Placement.
- Mr Guoga will receive 25 million options in the Company.
- Company expected to have over $18 million in cash at bank after capital raising.
- DigitalX's Bitcoin ETF demand has grown to over $54 million since July 2024.
- Clear strategic direction to maximize revenues from digital assets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Western Yilgarn NL (WYX) ORDINARY FULLY PAID |
Materials |
$6 |
Change in substantial holding
|
18 Dec 2024 9:26AM |
$0.026 |
$0.035 |
risen by
34.62%
|
|
| Hotel Property Investments (HPI) ORDINARY FULLY PAID |
Real Estate |
- |
Substantial Holder Notice from CQR
|
18 Dec 2024 9:26AM |
$3.790 |
$3.750 |
fallen by
1.06%
|
|
| Charter Hall Retail REIT (CQR) ORDINARY UNITS FULLY PAID |
Real Estate |
$2,380 |
Substantial Holder Notice for HPI
|
18 Dec 2024 9:26AM |
$3.230 |
$4.095 |
risen by
26.78%
|
|
| FireFly Metals Ltd (FFM) ORDINARY FULLY PAID |
Materials |
$1,328 |
Appointment of General Counsel and Company Secretary
|
18 Dec 2024 9:26AM |
$0.935 |
$1.945 |
risen by
108.02%
|
|
| Tower Limited (TWR) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Financials |
$579 |
Capital Return to Shareholders - Sealed Initial Court Orders
|
18 Dec 2024 9:25AM |
$1.185 |
$1.690 |
risen by
42.62%
|
|
| Patronus Resources Limited (PTN) ORDINARY FULLY PAID |
Materials |
$105 |
Board and Management Changes
|
18 Dec 2024 9:25AM |
$0.052 |
$0.071 |
risen by
36.54%
|
|
PTN - Price-sensitive ASX Announcement
Full Release
Key Points
- John Ingram appointed as Managing Director to drive Patronus’ growth strategy.
- Nicholas Anderson resigns as a non-executive Director to focus on new role.
- Ingram has over 25 years of experience in the mining industry.
- Management transition has been ongoing since August 2023.
- Patronus is preparing for an exciting year in 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Percheron Therapeutics Limited (PER) ORDINARY FULLY PAID |
Health Care |
$9 |
Topline Six-Month Results From Phase IIb Study of Avicursen
|
18 Dec 2024 9:25AM |
$0.059 |
$0.008 |
fallen by
86.44%
|
|
PER - Price-sensitive ASX Announcement
Full Release
Key Points
- Trial did not meet primary endpoint of PUL2.0 score at week 25.
- No statistically significant differences in secondary endpoints.
- Avicursen was safe and well-tolerated with mild injection site reactions.
- The study will be terminated as it is not in the best interests of patients or shareholders.
- Further data is expected in January 2025 to determine future steps.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tambourah Metals Ltd (TMB) ORDINARY FULLY PAID |
Materials |
$22 |
Proposed issue of securities - TMB
|
18 Dec 2024 9:24AM |
$0.025 |
$0.087 |
risen by
248%
|
|
| Apollo Minerals Limited (AON) ORDINARY FULLY PAID |
Materials |
$7 |
Exploration Update - Salanie Gold Project
|
18 Dec 2024 9:24AM |
$0.015 |
$0.008 |
fallen by
46.67%
|
|
| IPH Limited (IPH) ORDINARY FULLY PAID |
Industrials |
$909 |
Update - Notification of buy-back - IPH
|
18 Dec 2024 9:24AM |
$5.080 |
$3.475 |
fallen by
31.59%
|
|
| Tungsten Mining NL (TGN) ORDINARY FULLY PAID |
Materials |
$302 |
Proposed issue of securities - TGN
|
18 Dec 2024 9:23AM |
$0.080 |
$0.290 |
risen by
262.50%
|
|
| Tungsten Mining NL (TGN) ORDINARY FULLY PAID |
Materials |
$302 |
Capital Raising - Convertible Notes
|
18 Dec 2024 9:23AM |
$0.080 |
$0.290 |
risen by
262.50%
|
|
TGN - Price-sensitive ASX Announcement
Full Release
Key Points
- Tungsten Mining NL raised $4.5M via unsecured convertible notes.
- Funds will be used for acquiring the Mt Mulgine Project and general working capital.
- The capital raising highlights strong investor support for TGN's strategy.
- Each Convertible Note has a face value of $1,000 with a conversion price of $0.055.
- The interest rate on the Convertible Notes is set at 10% per annum.
- The maturity date for the Convertible Notes is 12 months from the issue date.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.